Lyell Immunopharma Goes All-In on AWS as its Cloud Provider

Cellular therapy company seeks to accelerate research of cell-based immunotherapies for cancer and other diseases by relying upon AWS’s unmatched portfolio of cloud services SEATTLE –(BUSINESS WIRE)–May 19, 2020– Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN),

Also Read Cloud Innovations at Africa's Radio Convention 2026